Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS605900B2 - Quantification method for antigenic substances - Google Patents
[go: Go Back, main page]

JPS605900B2 - Quantification method for antigenic substances - Google Patents

Quantification method for antigenic substances

Info

Publication number
JPS605900B2
JPS605900B2 JP51040908A JP4090876A JPS605900B2 JP S605900 B2 JPS605900 B2 JP S605900B2 JP 51040908 A JP51040908 A JP 51040908A JP 4090876 A JP4090876 A JP 4090876A JP S605900 B2 JPS605900 B2 JP S605900B2
Authority
JP
Japan
Prior art keywords
amount
antigen
antibody
solution
turbidity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP51040908A
Other languages
Japanese (ja)
Other versions
JPS52125623A (en
Inventor
賢司 秩父
清重 若林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP51040908A priority Critical patent/JPS605900B2/en
Publication of JPS52125623A publication Critical patent/JPS52125623A/en
Publication of JPS605900B2 publication Critical patent/JPS605900B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Description

【発明の詳細な説明】 本発明は抗原怪物質(但し、免疫グロプリンおよびァル
プミンは除く)の定量法に関するものであり、特に臨床
検査の上では先天性異常症、腎炎、貧血などの重症度の
判定、その他の疾患との鑑別に必要な血清蛋白質を迅速
かつ精度よく判定する為の定量法の発明である。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for quantifying antigenic substances (excluding immunoglobulin and alpmin), and is particularly useful in clinical tests to determine the severity of congenital abnormalities, nephritis, anemia, etc. This invention is a quantitative method for quickly and accurately determining serum proteins necessary for diagnosis and differentiation from other diseases.

一般に用いられている血清蛋白質の定量法としは、一元
平板免疫拡散法または試験管内単純拡散法の二つがある
There are two commonly used methods for quantifying serum proteins: one-dimensional plate immunodiffusion method and in vitro simple diffusion method.

これらの方法はいずれもゲル内拡散法を応用したもので
ある。一元平板免疫拡散法は、特異抗血清を含む寒天平
板の小孔に一定量の抗原(血清)を加え、一定の時間と
温度下におくと抗原はゲル内の抗体と反応しつつ拡散し
て小孔のまわりに白い沈降論を作る。
All of these methods apply the in-gel diffusion method. In the one-way plate immunodiffusion method, a certain amount of antigen (serum) is added to the small pores of an agar plate containing specific antiserum, and when the antigen is left for a certain period of time and at a certain temperature, the antigen diffuses while reacting with the antibodies in the gel. Creates a white sediment around the small hole.

その論の直径を測定し抗原量を定量する方法である。ま
た、一方の試験管内単純拡散法は、抗血清を寒天でゲル
化し、ガラス管につめ、その上に抗原(血清)を童層し
て抗原抗体反応により沈降物を生起せしめる。
This is a method to quantify the amount of antigen by measuring the diameter of the membrane. On the other hand, in the in vitro simple diffusion method, antiserum is gelled with agar, packed in a glass tube, and an antigen (serum) is placed on top of the gel to form a precipitate through an antigen-antibody reaction.

この場合沈降物はゲル内を移動しないが抗原過剰の状態
で解離し、さらに抗散した抗原が抗体と沈降物を作る。
こうして沈降線は鮮明な前線を保ちつつ抗体ゲル層中を
進行する。抗原と抗体が最適比となったところで沈降帯
が形成されるので、その拡散距離を測定することにより
抗原量を測定する方法である。しかし、これらいずれの
方方法も拡散や完全な沈降反応を起させるために長時間
、少くても1〜2日を必要とし、スケールを越えた抗原
量の場合にさらに1〜2日間もかかる。
In this case, the precipitate does not move within the gel, but dissociates in the presence of excess antigen, and the dispersed antigen forms antibodies and precipitates.
In this way, the sedimentation line advances through the antibody gel layer while maintaining a clear front. Since a sedimentation zone is formed when the antigen and antibody reach an optimal ratio, this method measures the amount of antigen by measuring the diffusion distance. However, all of these methods require a long time, at least 1 to 2 days, to cause diffusion and complete precipitation reactions, and even 1 to 2 days if the amount of antigen exceeds the scale.

またその測定も直径をルーペ等によって肉眼で読みとる
ために誤差を生じるという欠点があった。また、濁度計
を用いる方法も考えられているが、それは抗原量と沈降
物量との相関性を利用するものであるが、一般には抗原
抗体反応による沈降反応は抗体量を一定としたとき、抗
原量と沈降物量との間には第1図に示すような曲線で表
わされる関係があることが知られている。
Moreover, the measurement also had the disadvantage that errors occurred because the diameter was read with the naked eye using a magnifying glass or the like. In addition, a method using a turbidity meter has been considered, but this utilizes the correlation between the amount of antigen and the amount of sediment, but in general, precipitation reactions due to antigen-antibody reactions, when the amount of antibody is constant, It is known that there is a relationship between the amount of antigen and the amount of precipitate as represented by a curve as shown in FIG.

そのために同一沈降物量Aで算出される抗原量は、実際
には抗原不足域Xと抗原過剰城Yと測定点が二点存在す
ることになり、得られた値についての確認がさらに必要
になり多数の検体を正確に測定できる方法としては採用
し得ない。本発明者らは、これらの欠点を補うべく種々
研究した結果、あらかじめ各種抗原について、それぞれ
対応する一定量の抗体に対して抗原抗体反応沈降物量が
最大となるために必要な抗原量(以下「最適比量」とい
う)を求めておき、この量の抗原を反応系に加えて抗原
抗体反応を行なわせることにより濁度計から読みとれる
沈降物量から直接検体中の抗原量を知ることが可能とな
ることを見出し、さらに検討を加えて本発明を完成した
Therefore, the amount of antigen calculated from the same amount of sediment A actually has two measurement points: antigen deficient area X and antigen excess area Y, and further confirmation of the obtained value is required. This cannot be used as a method that can accurately measure a large number of specimens. As a result of various studies to compensate for these shortcomings, the present inventors have determined in advance the amount of antigen required to maximize the amount of antigen-antibody reaction precipitate (hereinafter referred to as " By determining the optimal ratio (referred to as "optimum ratio") and adding this amount of antigen to the reaction system to cause an antigen-antibody reaction, it is possible to directly determine the amount of antigen in the sample from the amount of sediment read from the turbidity meter. They found that this is true, and after further study, they completed the present invention.

すなわち本発明は「被検抗原およびその抗体からなる抗
原抗体反応の反応系に、最適比量を少し越した量の抗原
を共存せしめて抗原抗体反応を行なわせ、生成した抗原
抗体反応沈降物量を比濁法により測定することからなる
抗原性物質(但し、免疫グロプリンおよびアルブミンを
除く)の定量法である。本発明において「最適比量を少
し越した量」とは第1図において沈降物生成量が最大で
あるときの抗原量(最適比量)Zを少し越した量であっ
て沈降物生成量が減少いまじめるときの抗原量を指す。
In other words, the present invention is based on "an antigen-antibody reaction reaction system consisting of a test antigen and its antibody, in which an amount of antigen slightly exceeding the optimum ratio is allowed to coexist, an antigen-antibody reaction is performed, and the amount of the generated antigen-antibody reaction precipitate is reduced. This is a method for quantifying antigenic substances (excluding immunoglobulins and albumin) by measuring by turbidimetry.In the present invention, "an amount slightly exceeding the optimum ratio" refers to the amount of precipitate formed in Figure 1. This refers to the amount of antigen at which the amount of antigen slightly exceeds the maximum amount (optimal ratio Z) and the amount of precipitate produced decreases.

本発明でいう抗原性物質とは、抗体を作ることのできる
物質であり、例えば補体成分「パプトグロビン、トラン
スフエリン、ば,一アンチトリプシンなどの血清蛋白質
である。
The antigenic substance used in the present invention is a substance capable of producing antibodies, such as serum proteins such as complement components ``patoglobin, transferrin, and mono-antitrypsin.''

本発明によれば、第1図に示すように抗原過剰城Z以上
の曲線のみを使用することにより、各検体について濃度
変動をとる必要なく、その上従来行なわれていた抗原不
足域Xを利用した方法より検出感度が非常に良好である
According to the present invention, as shown in FIG. 1, by using only the curve above the antigen excess area Z, there is no need to take concentration fluctuations for each sample, and moreover, the antigen deficiency area The detection sensitivity is much better than that of the previous method.

本発明を実施するに当っては、まず「各種抗原性物質に
対する抗体原液を緩衝液例えばリン酸塩緩衝液、トリス
緩衝液、ベロナール緩衝液を含む生理食塩水で抗体力価
に応じて希釈する。
In carrying out the present invention, first, a stock solution of antibodies against various antigenic substances is diluted with a physiological saline containing a buffer such as phosphate buffer, Tris buffer, or veronal buffer according to the antibody titer. .

また、抗原性物質は、上記希釈抗体に対して最適比量を
少し越した量になるように緩衝液で希釈する。さらに、
測定する検体も測定範囲内濃度になるように緩衝液で希
釈する。次いで、希釈された検体、最適比量を少し越し
た抗原性物質および抗体を混合し直ちに濁度を測定する
Further, the antigenic substance is diluted with a buffer solution in an amount slightly exceeding the optimal ratio to the diluted antibody. moreover,
The sample to be measured is also diluted with a buffer solution so that the concentration falls within the measurement range. Next, the diluted specimen, antigenic substance and antibody at slightly higher than optimal ratios are mixed, and the turbidity is immediately measured.

(0時間測定値。検体の希釈倍率によっては、その濁り
を無視できる場合があり、その時は0時間測定する必要
ない。)その後ト10〜4000好ましくは20〜37
Cで一定時間放置後再び濁度を測定し、その差を真の抗
原抗体反応による濁度とする。このようにして得られた
値をあらかじめ各抗原性物質について各濃度の標準液に
ついて同機に濁度計で測定し作成された検量線から読み
取り検体中の抗原性物質量を迅速にかつ精度よく求める
ことができる。
(Measurement value at 0 hour. Depending on the dilution ratio of the sample, the turbidity may be ignored, and in that case, there is no need to measure at 0 hour.) After that,
After standing for a certain period of time at C, the turbidity is measured again, and the difference is taken as the turbidity due to the true antigen-antibody reaction. The values obtained in this way are measured in advance with a standard solution of each concentration of each antigenic substance on the same machine using a turbidity meter, and the amount of the antigenic substance in the sample is determined quickly and accurately by reading it from the calibration curve created. be able to.

濃た、本発明の方法を実際に用いるに当っては、次のよ
うな試薬キットにするとよい。
In order to actually use the method of the present invention, the following reagent kit may be used.

すなわち、{aー 検体を希釈するための緩衝液 ‘b} 至適量の抗原 ‘c} 抗原抗体反応に適当な濃度の抗体液‘dー 既
知量の抗原を含む各種濃度の標準抗原液をそれぞれの抗
原性物質について1セットとして取揃えることにより、
また、複数種の抗原性物質の測定用上記セットを同時に
組込むことによって使用者は所望のキットを選択し簡便
に同一検体について複数の抗原性物質を同時に測定する
ことも可能となる。
That is, {a- Buffer solution for diluting the specimen 'b} Optimum amount of antigen 'c} Antibody solution at an appropriate concentration for antigen-antibody reaction 'd- Standard antigen solutions of various concentrations containing known amounts of antigen, respectively By preparing one set of antigenic substances,
Furthermore, by simultaneously incorporating the above-mentioned sets for measuring multiple types of antigenic substances, the user can select a desired kit and easily measure multiple antigenic substances on the same specimen at the same time.

次に後述の実施例1および2における「最適比量を少し
越した量」の定め方を代表例として、本発明における「
最適比量を少し越した量」の定め方を「参考例」で説明
する。
Next, we will use the method of determining the "amount slightly exceeding the optimum ratio" in Examples 1 and 2, which will be described later, as a representative example.
How to determine the amount that slightly exceeds the optimal ratio will be explained using a "reference example."

〔参考例〕[Reference example]

抗原濃度が各々5,7,9,11,12,13,14,
15,17および19仏夕/血はとなるように濃度変化
させたトランスフェリン液に、それぞれリン酸塩緩衝液
で6M音‘こ希釈した抗トランスフェリン抗体液1.0
の‘を加えて総量を2.0舷とし、3700で約60分
間インキュベートした。
The antigen concentration is 5, 7, 9, 11, 12, 13, 14, respectively.
15, 17, and 19/Blood: Anti-transferrin antibody solution diluted with phosphate buffer to 6M in transferrin solution with varying concentrations as follows: 1.0
' was added to bring the total volume to 2.0 ships, and incubated at 3700 for about 60 minutes.

各抗原濃度における抗原抗体反応沈降物の生成量を濁度
計で測定し、その中での最大値を100としたときの割
合(沈降生成率)を第6図の如くグラフに表わした。こ
のグラフにおいて、沈降生成率100のときの抗原量1
3仏夕/tゆeが最適比量であり、「最適比量を少し越
した量」とは、沈降生成率が降下しはじめるときの抗原
量「 つまり14ムタ/tu戊とした。尚、「最適比量
を少し越した量」は抗体によって異なるので、抗体が変
わる毎に定める必要がある。次に実施例を挙げて説明す
る。
The amount of antigen-antibody reaction precipitate produced at each antigen concentration was measured using a turbidity meter, and the ratio (precipitate production rate) when the maximum value was set as 100 was expressed in a graph as shown in FIG. In this graph, the amount of antigen is 1 when the precipitation production rate is 100.
The optimal ratio is 3 m/t, and the "amount slightly exceeding the optimal ratio" means the amount of antigen when the sedimentation production rate begins to decrease.In other words, 14 m/t. The "amount slightly exceeding the optimal ratio" varies depending on the antibody, so it needs to be determined each time the antibody changes. Next, an example will be given and explained.

実施例 1 トランスフェリン14〃タ含有する0.001M−リン
酸塩緩衝液(pH7.4)0.95の‘「最適比量を少
し越した量」に、濃度変化させたトランスフェリン液0
.05私を添加し、0.01M−リン酸塩緩衝液(餌7
.4)を含む生理食塩水で6ぴ部こ希釈した抗体1.0
の‘を加え総量2.0泌とし37こ0で60分後にその
濠度を測定すると第2図に示すような、添加トランスフ
ェリンと沈降物量(濁度)との相関が求められた。
Example 1 0.001M phosphate buffer (pH 7.4) containing 14% transferrin The concentration of transferrin was changed to 0.95', an amount slightly exceeding the optimum ratio.
.. Add 0.05 I, 0.01M-phosphate buffer (bait 7
.. Antibody 1.0 diluted 6 times with physiological saline containing 4)
When the total amount of secretion was 2.0, and the turbidity was measured after 60 minutes at 37°C, a correlation between the added transferrin and the amount of sediment (turbidity) was determined as shown in FIG.

実施例 2 ヒト血清30検体を0.001M−リン酸緩衝液(pH
7.4)を含む生理食塩水でそれぞれ20倍に希釈し、
その各30r〆を試験管に探り、さらに1.0の‘のト
ランスフェリン液(14rタ相当量)を加え混合する。
Example 2 Thirty human serum samples were diluted with 0.001M phosphate buffer (pH
7.4) diluted 20 times with physiological saline containing
Place 30 liters of each in a test tube, add 1.0' transferrin solution (equivalent to 14 liters) and mix.

それぞれに1.0の‘の6針音希釈抗体液を加えて37
q0で反応せしめる。60分後に濁度計で測定して得ら
れた濁度から実施例1で求めたグラフよりヒト血清中の
トランスフヱリン量が測定され、その平均値は291の
9/d‘であった。
Add 6 needle diluted antibody solutions of 1.0' to each 37
Let it react at q0. The amount of transferrin in human serum was determined from the graph obtained in Example 1 from the turbidity measured with a turbidity meter after 60 minutes, and the average value was 9/d' of 291.

これは健康人の平均値に一致している。また、ここで用
いたヒト血清から1検体を任意にとりだし、これに既知
量のトランスフェリンを添加し上記と同様に測定し、そ
の回収率を調べた結果、高い回収率が得られた。
This is in line with the average value for healthy people. In addition, one sample was arbitrarily taken from the human serum used here, a known amount of transferrin was added to it, and the measurement was performed in the same manner as above, and the recovery rate was investigated. As a result, a high recovery rate was obtained.

実施例 3 ハブトグロビン15ムタ含有する0.001M−リン酸
塩緩衝液(pH7.4)0.95の‘「最適比量を少し
越した量」に濃度変化させたハプトグロビン液0.05
の‘を添加し、0.001M−リン酸塩緩衝液(pH7
.4)を含む生理食塩水で20倍に希釈した抗体1.0
の‘を加え総量2.0泌とし3700で60分後にその
濁度を測定すると第3図に示すような添加ハフ。
Example 3 0.001M phosphate buffer (pH 7.4) containing 15 habtoglobin 0.05 haptoglobin solution whose concentration was changed to 0.95' ``amount slightly exceeding the optimum ratio''
of 0.001M phosphate buffer (pH 7)
.. Antibody 1.0 diluted 20 times with physiological saline containing 4)
When the turbidity was measured after 60 minutes at 3700° C. as shown in Figure 3, the total amount was 2.0.

トグロビンと沈降物量(濁度)との相関が求められた。
また、実施例2と同様にして回収率を調べた結果、高い
回収率が得られた。実施例 4 補体の第3成分に318〃タ含有する0.001M−リ
ン酸塩緩衝液(pH7.4)0.95叫「最適比量を少
し越した量」に、濃度変化させた補体の第3成分C3液
0.05の‘を添加し、0.001M−リン酸塩緩衝液
(pH7.4)を含む生理食塩水で2ぴ部こ希釈した抗
体1.0の‘を加え総量2.0の上とし370で60分
後にその濁度を測定すると第4図に示すような、添加補
体の第3成分C3と沈降物量(濁度)との相関が求めら
れた。
The correlation between toglobin and the amount of sediment (turbidity) was determined.
Furthermore, as a result of examining the recovery rate in the same manner as in Example 2, a high recovery rate was obtained. Example 4 A 0.001M phosphate buffer (pH 7.4) containing 318% of the third component of complement was mixed with a supplement whose concentration was varied to 0.95% (amount slightly exceeding the optimal ratio). Add 0.05' of third component C3 solution and add 1.0' of antibody diluted 2 parts with physiological saline containing 0.001 M phosphate buffer (pH 7.4). When the total amount was above 2.0 and the turbidity was measured after 60 minutes at 370, the correlation between the third component C3 of the added complement and the amount of sediment (turbidity) was determined as shown in FIG.

また、実施例2と同様にして回収率を調べた結果、高い
回収率が得られた。
Furthermore, as a result of examining the recovery rate in the same manner as in Example 2, a high recovery rate was obtained.

実施例 5 Q,一アンチトリプシン28ムタ含有する0.001M
−べロナール緩衝液(pH7.4)0.95の‘(最適
比量を少し越した量)に、濃度変化させたQ,ーアンチ
トリプシン液0.05泌を添加し、0.001M−べロ
ナール緩衝液(pH7.4)を含む生理食塩水で20倍
に希釈した抗体1.0の‘を加え総量2.0Mとし、3
7q0で6■ふ後にその濁度を測定すると第5図に示す
ような、添加Q,ーアンチトリプシン量と沈降物量(濁
度)との相関が求められた。
Example 5 0.001M containing Q,1-antitrypsin 28 muta
- To 0.95' of Veronal buffer (pH 7.4) (an amount slightly exceeding the optimum ratio), 0.05 of Q,-antitrypsin solution of varying concentration was added, and 0.001M of Add 1.0% of the antibody diluted 20 times with physiological saline containing Ronal buffer (pH 7.4) to make a total volume of 2.0M.
When the turbidity was measured after 6 hours at 7q0, a correlation between the amount of added Q,-antitrypsin and the amount of sediment (turbidity) was determined as shown in FIG.

また、実施例2と同様に回収率を調べた結果、高い回収
率が得られた。
Furthermore, as a result of examining the recovery rate in the same manner as in Example 2, a high recovery rate was obtained.

実施例 6 次のようにハプトグロビン定量用試薬キットを作成した
Example 6 A reagent kit for quantifying haptoglobin was prepared as follows.

【a)緩衝液試験管:0.001Mーベロナール緩衝液
(pH7.4)を含む生理食塩水0.9の‘を収容した
小試験管。
(a) Buffer test tube: A small test tube containing 0.9' of physiological saline containing 0.001M veronal buffer (pH 7.4).

‘b}抗原液試験管:15メタの抗原を含む抗血清0.
98の‘を収容した小試験管。
'b} Antigen solution test tube: Antiserum containing 15 meta antigens 0.
A small test tube containing 98'.

【c}抗 体 液 瓶:抗体原液を0.001Mーベロ
ナール緩衝液(pH7.4)を含む生理食塩水で抗原抗
体反応に適し た濃度に希釈した抗体液1.0泌 を収容した瓶。
[c} Antibody solution bottle: A bottle containing 1.0 diluted antibody solution prepared by diluting the antibody stock solution with physiological saline containing 0.001M-Veronal buffer (pH 7.4) to a concentration suitable for antigen-antibody reactions.

‘dレ・プトグロビン標準液:種々の異なった濃度のハ
プトグロビン標準血清液を収容した小説験管。
'dreptoglobin standard solution: A novel test tube containing haptoglobin standard serum solutions of various different concentrations.

このように構成した定量用試薬キットは、次のようにし
て用いる。
The quantitative reagent kit constructed as described above is used in the following manner.

すなわち、0.1の‘の検体を緩衝液試験管【a}に採
取し、よく混合する。この混合液0.02叫を更に抗原
液試験管‘机ことり混合し、抗体液瓶‘cーから1叫の
抗体液をとり出し、試験管‘b}の混合液に添加し37
0で60分間放置する。次いで濁度計を用いて濁度を測
定する。別に検体に代え各種濃度のハプトグロビン標準
0液‘dーを用いて上記と同様の実験を繰り返し標準曲
線を得て、この標準曲線より検体中のハプトグロピン量
を求める。
That is, a sample of 0.1' is collected into a buffer test tube [a} and mixed well. 0.02 of this mixed solution was further mixed with the antigen solution in a test tube 'c', and one volume of antibody solution was taken out from the antibody solution bottle 'c' and added to the mixed solution in test tube 'b'.
0 for 60 minutes. The turbidity is then measured using a turbidity meter. Separately, the same experiment as above is repeated using haptoglobin standard 0 solution 'd- of various concentrations instead of the specimen to obtain a standard curve, and the amount of haptoglobin in the specimen is determined from this standard curve.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は抗原抗体反応における沈降物量の変化を示す曲
線であり、第2図は実施例1のトランスフェリン量と沈
降物量との相関性を示す曲線であり、第3図は実施例3
のハプトグロビン量と沈降物量との相関性を示す曲線で
あり、第4図は実施例4の橘体の第3成分に3量と沈降
物量との相関性を示す曲線であり、第5図は実施例5の
Q,一アンチトリプシン量と沈降物量との相関性を示す
曲線である。 第6図は「参考例」における「最適比量を少し越した量
」を定めるためのグラフである。第1図 第2図 第3図 第4図 第5図 第6図
FIG. 1 is a curve showing the change in the amount of precipitate in the antigen-antibody reaction, FIG. 2 is a curve showing the correlation between the amount of transferrin and the amount of precipitate in Example 1, and FIG. 3 is a curve showing the correlation between the amount of transferrin and the amount of precipitate in Example 3.
FIG. 4 is a curve showing the correlation between the amount of haptoglobin and the amount of sediment in Example 4, and FIG. 3 is a curve showing the correlation between the amount of Q, antitrypsin and the amount of sediment in Example 5. FIG. 6 is a graph for determining the "amount slightly exceeding the optimum ratio" in the "reference example". Figure 1 Figure 2 Figure 3 Figure 4 Figure 5 Figure 6

Claims (1)

【特許請求の範囲】[Claims] 1 被検抗原およびその抗体からなる抗原抗体反応の反
応系に、最適比量を少し越した量の抗原を共存せしめて
抗原抗体反応を行なわせ、生成した抗原抗体反応沈降物
量を比濁法により測定することを特徴とする抗原性物質
(但し免疫グロブリンおよびアルブミンを除く)の定量
法。
1. The antigen-antibody reaction system consisting of the test antigen and its antibody is made to coexist with an amount of antigen slightly exceeding the optimal ratio to perform the antigen-antibody reaction, and the amount of the generated antigen-antibody reaction precipitate is measured by turbidimetry. A method for quantifying antigenic substances (excluding immunoglobulin and albumin).
JP51040908A 1976-04-13 1976-04-13 Quantification method for antigenic substances Expired JPS605900B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP51040908A JPS605900B2 (en) 1976-04-13 1976-04-13 Quantification method for antigenic substances

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51040908A JPS605900B2 (en) 1976-04-13 1976-04-13 Quantification method for antigenic substances

Publications (2)

Publication Number Publication Date
JPS52125623A JPS52125623A (en) 1977-10-21
JPS605900B2 true JPS605900B2 (en) 1985-02-14

Family

ID=12593594

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51040908A Expired JPS605900B2 (en) 1976-04-13 1976-04-13 Quantification method for antigenic substances

Country Status (1)

Country Link
JP (1) JPS605900B2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60188846A (en) * 1984-03-08 1985-09-26 Hitachi Ltd Automatic analysis method
JPS63246667A (en) * 1987-03-31 1988-10-13 Kyoto Ikagaku Kenkyusho:Kk Detection of hemoglobin in excrement
JPS63246668A (en) * 1987-03-31 1988-10-13 Kyoto Ikagaku Kenkyusho:Kk Detection of occult blood in excrement
JPH0635976B2 (en) * 1988-09-24 1994-05-11 株式会社島津製作所 Prozone determination method in immune reaction
CN1307422C (en) * 2005-01-31 2007-03-28 上海市血液中心 An antigen-antibody dilution liquid and quality controlled produce formed thereby
CN107966567B (en) * 2017-11-21 2018-12-18 浙江夸克生物科技有限公司 A kind of haptoglobin assay kit

Also Published As

Publication number Publication date
JPS52125623A (en) 1977-10-21

Similar Documents

Publication Publication Date Title
Killingsworth et al. Manual nephelometric methods for immunochemical determination of immunoglobulins IgG, IgA, and IgM in human serum
Killingsworth et al. Nephelometric studies of the precipitin reaction: a model system for specific protein measurements
Lizana et al. Manual immunonephelometric assay of proteins, with use of polymer enhancement
Killingsworth et al. Automated immunochemical procedures for measurement of immunoglobulins IgG, IgA, and IgM in human serum
Luxton et al. A micro-method for measuring total protein in cerebrospinal fluid by using benzethonium chloride in microtiter plate wells.
Ellis et al. New approach to evaluation of proteinuric states
CN102175871A (en) Liquid double-reagent kit for measuring free light chains in serum or urine by double-latex method
Buffone et al. Evaluation of kinetic light scattering as an approach to the measurement of specific proteins with the centrifugal analyzer. I. Methodology
CN102841206A (en) Troponin-T determination kit
US4091089A (en) Method for quantitative determination of an antigenic substance
NO149864B (en) IMMUNOLOGICAL REAGENT.
Van Lente et al. Evaluation of a nephelometric assay for haptoglobin and its clinical usefulness.
JPS605900B2 (en) Quantification method for antigenic substances
JP3513075B2 (en) Immunoassay and reagent therefor
CN110133270A (en) A kind of enhancing immunosupress is than turbid antibody screening reagent and its making and use method
JPS6345066B2 (en)
JP3212128B2 (en) Immunological assay using colloidal gold
CA1162846A (en) Hemolytic method for the continuous determination of antistreptolysin o antibodies in blood or serum samples, using oxidised streptolysin o
JPH01301165A (en) Immunoassay
D'orazio et al. Potentiometric electrode measurement of serum antibodies based on the complement fixation test
JPS58211659A (en) Handy and quick assay of serum crp by immunological nephelometry
Killingsworth et al. Nephelometric methods for the determination of urinary albumin, transferrin and alpha-2 macroglobulin
Buffone et al. Effect of analytical factors on immunochemical reference limits for complement component C3 in serum of a reference pediatric population.
JPS58182558A (en) Method of measuring antigen
JPH08292192A (en) Immunoassay